| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |